1,25-Dihydroxyvitamin D3 upregulates the phosphatidylinositol signaling pathway in human keratinocytes by increasing phospholipase C levels.

S Pillai; D D Bikle; M J Su; A Ratnam; J Abe

doi:10.1172/JCI118075

Department of Medicine, University of California, San Francisco, USA.

Find articles by Pillai, S. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Francisco, USA.

Find articles by Bikle, D. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Francisco, USA.

Find articles by Su, M. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Francisco, USA.

Find articles by Ratnam, A. in: JCI | PubMed | Google Scholar

Department of Medicine, University of California, San Francisco, USA.

Find articles by Abe, J. in: JCI | PubMed | Google Scholar

Published in Volume 96, Issue 1 on July 1, 1995
J Clin Invest. 1995;96(1):602–609. https://doi.org/10.1172/JCI118075.
© 1995 The American Society for Clinical Investigation

Published July 1, 1995 - Version history

1,25-Dihydroxyvitamin D3 (1,25(OH)2D3) induces the differentiation of normal human keratinocytes, in part by increasing their basal intracellular calcium levels (Cai) over a period of hours. Agonists such as ATP acting through membrane receptors cause an immediate but transient increase in Cai accompanied by an increase in inositol trisphosphate (IP3). Treatment of keratinocytes for 24 h with 1 nM 1,25(OH)2D3 resulted in a two- to four-fold potentiation of the Cai response of these cells to ATP. This potentiation was inhibitable with cycloheximide, unaccompanied by a change in total intracellular calcium pools, but associated with an increase in basal IP3 levels and ATP-stimulated IP3 production. Treatment with 1,25(OH)2D3 raised the protein and mRNA levels of phospholipase C isoenzymes, particularly phospholipase C-beta 1 in a dose-dependent manner. These studies indicate that 1,25(OH)2D3 modulates the keratinocyte signal transduction pathway by induction of phospholipase isoenzymes, a previously undescribed action for this hormone.

Images.